Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)

China flag China · Delayed Price · Currency is CNY
24.02
-0.25 (-1.03%)
At close: Mar 9, 2026
34.12%
Market Cap 2.69B
Revenue (ttm) 196.21M
Net Income (ttm) 51.71M
Shares Out 108.22M
EPS (ttm) 0.48
PE Ratio 51.88
Forward PE n/a
Dividend 0.32 (1.33%)
Ex-Dividend Date Sep 26, 2025
Volume 1,156,245
Average Volume 1,599,183
Open 23.90
Previous Close 24.27
Day's Range 23.61 - 24.22
52-Week Range 14.46 - 28.93
Beta 0.54
RSI 51.08
Earnings Date Apr 25, 2026

About SHA:688163

Shanghai Serum Bio-Technology Co., Ltd. engages in the research, development, production, operation, and sales of antitoxin and antiserum products in China. It offers equine anti-tetanus immunoglobulin, anti-venin, and anti-rabies serum products. The company was founded in 1999 and is based in Shanghai, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 324
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688163
Full Company Profile

Financial Performance

In 2025, SHA:688163's revenue was 196.21 million, an increase of 0.66% compared to the previous year's 194.92 million. Earnings were 51.71 million, an increase of 16.76%.

Financial Statements

News

There is no news available yet.